ARCHIVES

September issue of Business & Regulatory Report included–8 additional pages of industry news.

This article is from The Cancer Letter archive.

Vol. 30 No. 37 | October 1, 2004

Download PDF Visit The Full Archive

Related Articles

President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass

February 8, 1991

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

Guidelines Adopted For Pathology Review

February 22, 1980

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990